|
Rosado-Jiménez L., Mestre-Terkemani Y., García-Aliaga Á., Sarabia-Meseguer M.D., Marín-Vera M., Macías-Cerrolaza J.A., Sánchez-Henarejos P., García-Hernández M.R., Zafra-Poves M., Álvarez-Abril B.C., López-Sánchez C.B., Moya-Martínez M.P., Pascual-Gilabert P., Cerón-Moreno A.M., Castillo-Guardiola V., Antón-Martínez D., Ayala-de la Peña F., Alonso-Romero J.L., Noguera-Velasco J.A., Ruiz-Espejo F. Functional characterization of splice variants in hereditary breast and ovarian cancer susceptibility genes. Familial Cancer. March 2026. 25. 10.1007/s10689-025-00521-4
AÑO: 2026; IF: 2.0
|
|
Almanchel-Rivadeneyra M, Alonso Romero JL, Tomas-Luiz A, Diaz Carrasco MS. Drug-drug interactions in adjuvant and neoadjuvant breast cancer therapy. Eur J Hosp Pharm. 2026 Jan 6:ejhpharm-2025-004761. doi: 10.1136/ejhpharm-2025-004761. Online ahead of print. PubMed PMID: 41494827.
AÑO: 2026; IF: 1.5
|
|
Alonso-Romero JL, Martinez-Garcia J, Carrillo-Vicente R, Aramburo AF, Diez AF, Henarejos PS, de la Morena Barrio P, Boix AP, Jimenez MD, Siles JP, Maestre JAP, de Las Heras-Rubio A, Carreno PR. Translational and real-world evidence of trastuzumab biosimilar CT-P6 plus pertuzumab in neoadjuvant HER2-positive early breast cancer. Breast Cancer Res Treat. 2026 Jan 20;215(2):60. doi: 10.1007/s10549-026-07895-8. PubMed PMID: 41557021; PubMed Central PMCID: PMC12819485.
AÑO: 2026; IF: 3.0
|
|
Lopez-Tarruella S, Guerrero-Zotano A, Antolin S, Cruz J, Martinez P, Rodriguez CA, Falo C, Rodriguez-Lescure A, Adrover E, Hernandez M, Andres R, Chacon JI, Alonso Romero JL, Miguel A, Gomez-Raposo C, Margeli M, Gonzalez I, Guerra JA, Anton A, Tibau A, Miralles JJ, Escudero MJ, Bezares S, Rojo F, Alvarez I. Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM). Ther Adv Med Oncol. 2026 Feb 20;18:17588359261421813. doi: 10.1177/17588359261421813. eCollection 2026. PubMed PMID: 41732657; PubMed Central PMCID: PMC12924966.
AÑO: 2026; IF: 4.2
|
|
Encarnacion JA, Ibanez N, De la Fuente I, Ruiz P, Gonzalez S, Quiles B, Sanchez M, Bautista Y, Rodriguez C, Nadal JA, Marin M, Marin-Zafra G, Guirao M, Hernandez Q, Abrisqueta J, Abellan I, Montoya M, Ono A, Carbonell G, Frutos L, Ortiz E, Manso C, Royo-Villanova M, Alonso-Romero JL. Clinical Complete Response and Organ Preservation Strategies in Rectal Cancer: A Real-World Single-Center Experience Clinical Complete Response and Organ Preservation in Rectal Cancer. Cancers (Basel). 2026 Feb 27;18(5):763. doi: 10.3390/cancers18050763. PubMed PMID: 41827698; PubMed Central PMCID: PMC12985280.
AÑO: 2026; IF: 4.4
|
41410715